TITLE
Androgen receptor antagonist to agonist conversion

SUMMARY
Examination of antagonist to agonist conversion in androgen receptor-expressing hormone-sensitive LNCaP prostate cancer cells. Cells challenged with increasing doses of R1881, or bicalutamide.

ORGANISM
Homo sapiens

PLATFORM
GPL96 : [HG-U133A] Affymetrix Human Genome U133A Array

CITATIONS
Chen CD, Welsbie DS, Tran C, Baek SH et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004 Jan;10(1):33-9. PMID:Â  14702632

